FDA Adds 37 Chinese Food Packaging Firms to Import Alert

Agri-tech Specialist
May 16, 2026

On May 13, 2026, the U.S. Food and Drug Administration (FDA) updated Import Alert #77-08, adding 37 Chinese food packaging manufacturers to its automatic detention list — primarily due to failure to submit FSMA Section 204 traceability key data records and absence of a signed Foreign Supplier Verification Program (FSVP) supplier compliance statement. Companies involved in carton packaging, label printing, and eco-friendly packaging are directly affected, with shipments subject to detention at U.S. ports of entry. This development warrants close attention from exporters, packaging suppliers, and importers engaged in U.S.-China food-related supply chains.

Event Overview

The U.S. FDA issued an update to Import Alert #77-08 on May 13, 2026, listing 37 newly added Chinese food packaging enterprises. The stated reasons for inclusion are non-submission of required traceability records under FSMA Section 204 and lack of a valid FSVP supplier compliance statement. The alert applies to products falling under carton packaging, label printing, and eco-friendly packaging categories. Affected goods are subject to automatic detention upon arrival at U.S. entry points.

Industries Impacted by Category

Direct Exporters & Trading Companies

These entities face immediate shipment delays or rejections if their U.S. consignees cannot demonstrate FSMA-compliant documentation. Since FDA’s detention is applied at the importer-of-record level, trading companies acting as U.S. agents or designated importers bear direct regulatory responsibility — even when not physically handling the goods.

Raw Material & Component Suppliers

Suppliers providing substrates (e.g., food-grade paperboard, inks, adhesives) to the listed packaging firms may experience downstream demand pressure. While not directly named in the alert, their traceability systems and documentation practices may be scrutinized during FSVP audits conducted by U.S. importers seeking to validate upstream compliance.

Contract Packaging & Converter Manufacturers

Firms producing finished packaging for branded food products — especially those serving U.S. clients — must now verify whether their own FSMA recordkeeping meets Section 204 requirements. The alert signals that FDA is treating packaging as part of the food supply chain’s traceability scope, not merely as incidental material.

Distribution & Logistics Providers

Third-party logistics (3PL) providers managing customs clearance or warehousing for affected shipments may encounter increased documentation requests from U.S. importers. Detention triggers require formal FDA responses, including evidence of corrective action — tasks often coordinated through logistics partners.

Key Focus Areas and Immediate Actions for Stakeholders

Monitor official FDA communications and alert revisions

Import Alert #77-08 remains active and subject to further updates. Stakeholders should subscribe to FDA’s Import Alert email notifications and regularly review the agency’s public database for additions, removals, or clarifications — particularly regarding criteria for removal (e.g., submission of corrective documentation).

Verify FSMA Section 204 recordkeeping scope for packaging materials

Analysis shows that FDA now explicitly includes certain packaging components within the definition of “food” for traceability purposes under FSMA. Companies should assess whether their packaging production processes generate records required under Section 204 — including lot numbers, receiving dates, transformation steps, and distribution events — and ensure retention for two years.

Distinguish between FSVP signature requirements and actual verification activities

Observably, the presence of a signed FSVP supplier compliance statement alone does not satisfy FDA expectations. U.S. importers must also conduct risk-based verification (e.g., onsite audits, sampling, review of food safety plans). Affected Chinese firms should prepare for potential requests from their U.S. partners to share supporting evidence beyond the signed statement.

Review and align documentation across the supply tier

Current more appropriate preparation involves mapping documentation flows across tiers: from raw material suppliers → converters → finished packaging producers → U.S. importers. Gaps in traceability handoffs — such as missing batch linkage between ink lots and final carton batches — represent high-risk exposure points identified in recent FDA guidance.

Editorial Perspective / Industry Observation

This alert is better understood as a signal of intensified enforcement focus — rather than an isolated incident. From an industry perspective, FDA’s action reflects a broader shift toward treating packaging as an integral, regulated element of food traceability, not just ancillary equipment. It does not yet indicate a new rulemaking, but rather operational application of existing FSMA authorities. Observably, the timing coincides with FDA’s ongoing implementation of the Food Traceability Rule (21 CFR Part 119), suggesting alignment between inspection priorities and digital traceability readiness. Continued monitoring is warranted, as similar actions may expand to other export-oriented packaging clusters in the coming months.

FDA Adds 37 Chinese Food Packaging Firms to Import Alert

In summary, this FDA action underscores that compliance with U.S. food safety regulations now extends meaningfully to packaging producers — not only to food manufacturers. It highlights the operational importance of traceability documentation and supplier verification in cross-border food supply chains. Rather than representing a sudden policy change, it is more appropriately interpreted as an enforcement milestone confirming long-standing statutory obligations under FSMA.

Source: U.S. FDA Import Alert #77-08 (updated May 13, 2026); FDA Guidance for Industry: Requirements for Additional Traceability Records for Certain Foods (Final Rule, 21 CFR Part 119); FDA FSVP Final Rule (21 CFR Part 1, Subpart L).
Note: Ongoing observation is recommended for any future FDA statements clarifying the applicability of Section 204 to packaging-specific record types or removal criteria for listed firms.

Recommended News

Global Trade Insights & Industry

Our mission is to empower global exporters and importers with data-driven insights that foster strategic growth.